Welcome to our dedicated page for OneMedNet SEC filings (Ticker: ONMDW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on OneMedNet's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into OneMedNet's regulatory disclosures and financial reporting.
OneMedNet reported mixed results: operating revenue declined while non-operating items improved the bottom line. Total revenue was $155 thousand for the quarter (subscription $47k; web imaging $108k), down from $227k year-over-year, and gross margin was negative $(241)k. The company recorded net income of $2.98 million for the quarter and $1.08 million for the six months, driven largely by a $3.71 million gain on troubled debt restructurings, realized Bitcoin gains, and fair value adjustments.
Balance sheet and liquidity remain constrained: cash was $122k and Bitcoin fair value $1.598 million (15 units), total assets $2.337 million, and total liabilities fell to $6.177 million from $19.677 million due to debt-to-equity conversions and settlements. Stockholders' deficit improved to $(3.84) million. Management states the cash and Bitcoin balance are not adequate to fund operations for 12 months, raising substantial doubt about going concern and requiring additional financing.